Trial starts of malaria vaccine in 2000 children in MozambiqueBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7407.124-b (Published 17 July 2003) Cite this as: BMJ 2003;327:124
- Anne Gulland
Researchers hope to see the first results from the largest ever malaria vaccine trial in children in Africa in just 18 months, the research team leader announced last week.
Phase two clinical trials of the most advanced malaria vaccine were due to start last Monday in 2000 children aged between 1 and 4 years in Mozambique.
Pedro Alonso, head of the Centre for International Health at the University of Barcelona, Spain, and principal investigator of the vaccine trial, told a press conference earlier this week: “The screening of the children has been completed, and we hope to have the results one and a …